Our Stories


Janssen, the pharmaceutical division of Johnson & Johnson, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neurosciences & analgesia, dermatology, infectious diseases and metabolic diseases in India.

Driven by a strong commitment to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world. Janssen recognizes the impact of serious conditions on people’s lives, and aims to empower people through disease awareness, education and access to quality care. Learn More about Janssen

  • Metabolic disorders

    Through pharmaceutical research and development efforts, Janssen is creating innovative solutions and medications that can help patients live a better life with diabetes.

  • Immunology

    Building upon a long-standing commitment to immunology, the Company continues to deliver new options to combat complex conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel diseases and psoriasis.

  • Dermatology

    The company’s vision is to make a meaningful difference in the lives of patients suffering from dermatological disorders. The focus is on skin, hair and nail diseases, with an innovative product range adding value for better management of dermatological diseases.

  • Infectious diseases

    With the goal of improving public health by fighting infectious diseases, the company is committed to delivering treatment for people living with multi drug resistant tuberculosis.

  • Neurosciences & Analgesia

    With a continued, deep-rooted commitment to neuroscience, the company’s vision is to reduce the burden, disability and devastation caused by serious neuropsychiatric diseases and pain conditions, and restore hope for patients. The areas of focus include: Neurology, which includes Alzheimer’s disease; Psychiatry, such as schizophrenia and mood disorders such as bipolar disease and major depressive disorder; and Schizophrenia and Pain, with special focus on chronic pain states and neuropathic pain.

  • Oncology

    Through groundbreaking research and innovative partnerships, Janssen aims to transform cancer into a preventable or curable disease. The Company’s goal is to deliver therapeutic options that prolong and improve patients’ lives. Janssen is focused on key cancer types, including hematologic malignancies, prostate cancer, ovarian cancer and soft tissue sarcomas. It is dedicated to helping realize the promise of winning the “war on cancer”.